ECE2023 Poster Presentations Pituitary and Neuroendocrinology (123 abstracts)
Grading of pituitary adenomas (PitNets): clinical and prognostic implications in a monocentric series
Giuseppe Giuffrida 1 , Rosalinda Casablanca 2 , Marta Ragonese 3 , Salvatore Giovinazzo 3 , Oana Ruxandra Cotta 2 , Rosaria Certo 2 , Ylenia Alessi 3 , Marianna Scordo 2 , Cristina Pizzimenti 4 , Giovanni Tuccari 5 , Filippo Flavio Angileri 4 , Francesco Ferraù 2,3 & Salvatore Cannavò 2,3
1Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy; 2Endocrine Unit, ‘G. Martino’ University Hospital, Messina; 3Department of Human Pathology of Adulthood and Childhood, University of Messina; 4Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina; 5Department of Human Pathology of Adulthood and Childhood, Section of Pathology, University of Messina
Rationale: Pituitary neuroendocrine tumors (PitNets) are aggressive in 20% of cases, with local invasion, relapse/scarce response to conventional treatment, in the absence of reliable predictive parameters. In 2018, Trouillas et al. proposed a 5-tier prognostic classification, not widely validated yet. In our study we evaluated the outcomes of a PitNets monocentric series in the context of this classification.
Materials & Methods: We retrospectively evaluated 88 patients (51 M, 50.5±14.7 yrs) with functioning (FPA) or non-functioning pituitary macroadenomas (NFPA), referred to the Endocrine Unit of Messina University Hospital, and operated by the same neurosurgeon in the period 2015-2020. Of each patient we recorded demographic, clinical, radiological, biochemical data and visual field, both at diagnosis/last follow-up (median 3±1.5 yrs), therapeutical history and pathological data. Once defined the PitNets grade according to Trouillas et al., we correlated it to clinico-pathological features at diagnosis, and to the outcomes (last follow-up).
Results: 38.6% of patients were in the 1a grade, 7.9% in the 1b, 48.9% and 4.5% among 2a and 2b, respectively. Of 10 giant PitNets, 70% were 2a. At diagnosis, panhypopituitarism and visual field alterations were higher among 2a. GH-omas were significantly prevalent among 1a tumors, NFPA among 2a. 1a and 2a grade PitNets had a better response to single surgery (P<0.01), while cyberknife stereotactic radiotherapy was needed in 2a and 2b tumors. Panhypopituitarism/visual field alterations were more frequent among 2a PitNets even after surgery. Ki-67 was positively associated to persistent disease in FPA, while radiological invasion was associated to remnant presence among NFPA.
Conclusions: Invasive and not-proliferating PitNets (2a) were more frequently associated to impaired pituitary function/visual field before and after surgery. Less proliferating tumors (1a and 2a) were more responsive to surgery. Ki-67 related to disease persistence in FPA, while adiuvant radiotherapy was more used among invasive tumors. Thus, among ±1 cm PitNets, tumor invasion influences clinico-biochemical outcomes, while Ki-67 influences surgical outcomes.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more